Login / Signup

A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City.

Jennifer A FronteraSakinah SabadiaRebecca LalchanTaolin FangBrent FlustyPatricio Millar VernettiThomas SnyderStephen BergerDixon YangAndre GrangerNicole MorganPalak S PatelJosef GutmanKara R MelmedShashank AgarwalMatthew BokhariAndres AndinoEduard ValdesMirza OmariAlexandra KvernlandKaitlyn LillemoeSherry H-Y ChouMolly McNettRaimund HelbokShraddha MainaliEricka L FinkCourtney RobertsonMichelle SchoberJose I SuarezWendy ZiaiDavid MenonDaniel FriedmanDavid FriedmanManisha HolmesJoshua HuangSujata ThawaniJonathan HowardNada Abou-FayssalPenina KriegerAriane LewisAaron S LordTing ZhouD Ethan KahnBarry M CzeislerJose TorresShadi YaghiKoto IshidaErica ScherAdam de HavenonDimitris PlacantonakisMengling LiuThomas M WisniewskiAndrea B TroxelLaura BalcerSteven Galetta
Published in: Neurology (2020)
Neurologic disorders were detected in 13.5% of patients with COVID-19 and were associated with increased risk of in-hospital mortality and decreased likelihood of discharge home. Many observed neurologic disorders may be sequelae of severe systemic illness.
Keyphrases
  • healthcare
  • early onset
  • drug induced